CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
Clinical trial NCT03706326 · UNKNOWN
Trial details
- NCT number
- NCT03706326
- Sponsor
- The First Affiliated Hospital of Guangdong Pharmaceutical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-28
- Primary completion
- 2021-09-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.